Suppr超能文献

[ASO 血瘀证血清对血管内皮细胞损伤的影响及桃红四物汤对其的调控作用]

[Effect of ASO Blood Stasis Syndrome Serum on Vascular Endothelial Cell Injury and Regulation of Taohong Siwu Decoction on it].

作者信息

Li Xin, Li Da-yong, Chen Wen-na, Zhang Yang, Liu Bao-qing, Li Shi-zheng, Hou Jun-jie

出版信息

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015 Nov;35(11):1373-7.

Abstract

OBJECTIVE

To explore the effect of arteriosclerosis obliterans (ASO) blood stasis syndrome (BSS) serum on vascular endothelial cell injury and to study the regulation of Taohong Siwu Decoction (TSD) on it.

METHODS

Umbilical vein endothelial cell culture system was established. The serum endothelial cell injury model with ASO BSS was prepared. Low, medium, and high concentrations TSD containing serums were respectively added. The endothelial cell proliferation activity was observed by MTT method. Ultrastructures of endothelial cells were observed under transmission electron microscope. Changes of intracellular calcium ion concentration and the cytoskeleton were observed under laser confocal microscope. Contents of ET, NO, and transforming growth factor beta1 (TGF-beta1) in endothelial cell culture supernatant were detected by ELISA.

RESULTS

In ASO BSS serum group endothelial cell proliferation activities decreased, the cell structure was obviously destroyed, calcium ion concentration increased, contents of ET, NO and TGF-beta1 increased significantly (P < 0.01), and ET/NO ratio was imbalanced. After incubating with TSD drug containing serum, endothelial cell proliferation activities and injured cell structures were obviously improved; ET, NO and TGF-beta1 levels decreased (P < 0.05, P < 0.01), ET/NO ratios approximated to the normal level.

CONCLUSION

The main mechanism of TSD for treating ASO ASS lied in improving injured vascular endothelial cells and endocrine disorder.

摘要

目的

探讨动脉硬化闭塞症(ASO)血瘀证血清对血管内皮细胞损伤的影响,并研究桃红四物汤(TSD)对其的调控作用。

方法

建立脐静脉内皮细胞培养体系,制备ASO血瘀证血清内皮细胞损伤模型,分别加入低、中、高浓度含TSD血清,采用MTT法观察内皮细胞增殖活性,透射电镜观察内皮细胞超微结构,激光共聚焦显微镜观察细胞内钙离子浓度及细胞骨架变化,ELISA法检测内皮细胞培养上清液中ET、NO及转化生长因子β1(TGF-β1)含量。

结果

ASO血瘀证血清组内皮细胞增殖活性降低,细胞结构明显破坏,钙离子浓度升高,ET、NO及TGF-β1含量显著增加(P<0.01),ET/NO比值失衡。含TSD药物血清作用后,内皮细胞增殖活性及受损细胞结构明显改善;ET、NO及TGF-β1水平降低(P<0.05,P<0.01),ET/NO比值接近正常水平。

结论

TSD治疗ASO血瘀证的主要机制在于改善受损血管内皮细胞及内分泌紊乱。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验